fda indications for tirzepatide Approves Tirzepatide, A Potential Blockbuster Drug Type 2 Diabetes FDA says shortage of GLP-1

Your appetite is down, the scale is moving in the right direction, and then boom

Available at: Staresinic M, et al

Learn more about our Hormone Replacement Therapy options

At Baton Rouge General we have several medical weight loss options for patients to choose from depending on your needs, insurance and more

Innate lymphoid cells: potential targets for cancer therapeutics

5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg/mL 200 mcg dose = 8 units (0.08 mL) on a 100-unit insulin syringe 300 mcg dose = 12 units (0.12 mL) on a 100-unit insulin syringe Doses per vial: 25 doses at 200 mcg, or ~16 doses at 300 mcg Supplies Needed (12-Week Cycle at 200 mcg 3x Daily) 11 vials Ipamorelin (5 mg each) provides 55 mg total, covers 252 doses of 200 mcg with margin 3 vials bacteriostatic water (30 mL each) 252 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique Ipamorelin is administered via subcutaneous (SubQ) injection